Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (3y) (2013 - 2025)
Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.98 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Jun 30, 2023 | 17.20 Mn |
| Jun 30, 2022 | -6.66 Mn |
| Dec 31, 2020 | -1.71 Mn |
| Jun 30, 2020 | -18.49 Mn |
| Mar 31, 2020 | 20,079.00 |
| Dec 31, 2019 | -6,682.00 |
| Mar 31, 2019 | -70,278.00 |
| Dec 31, 2018 | -36,786.00 |
| Sep 30, 2018 | 421,670.00 |
| Jun 30, 2018 | 830,035.00 |
| Mar 31, 2018 | 112,700.00 |
| Dec 31, 2017 | -7,835.00 |
| Sep 30, 2017 | 493,601.00 |
| Jun 30, 2017 | 264,198.00 |
| Mar 31, 2017 | 1.05 Mn |
| Dec 31, 2016 | 134,473.00 |
| Mar 31, 2016 | 662,448.00 |
| Dec 31, 2015 | 963,305.00 |